Home » FDA Hints at Potential Metrics and Collection Methods
FDA Hints at Potential Metrics and Collection Methods
Drugmakers may soon have to report to the FDA how they decide when to launch a CAPA investigation, if they have a performance index for their product’s critical quality attributes and the seniority level of the employee who signs off on the annual product review.
Drug GMP Report
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May